News

Granata Bio Raises $14M in Series A Funding to Enhance Fertility Treatment Options

Granata Bio, a biopharma company specializing in fertility medications, has announced the closure of a $14 million Series A funding round. Led by GV (Google Ventures), this funding round includes significant contributions from CooperSurgical, Gedeon Richter, Alumni Ventures, Amboy Street Ventures, Vibe Bio, and others. The investment aims to accelerate the development of Granata Bio’s fertility biopharma pipeline, addressing a critical gap…

Health Innovation Hub Ireland’s First Femtech Innovation Call Unveils 11 Winning Startups

Ireland’s first Femtech Innovation Call, organized by Health Innovation Hub Ireland (HIHI), has culminated in the selection of 11 promising startups focused on improving women’s healthcare. This initiative is an advancement in the country’s commitment to women’s health innovations, addressing a range of areas from fertility and menopause to fitness and chronic conditions like Parkinson’s in women. The 11 Winning Startups and…

The Diagnostic Potential of Menstrual Blood

Wow wow wow. We really started the year with a bit of a bang đź’Ą in women’s health last week: In a somewhat historic advancement for women’s health, Qvin’s received FDA approval of the Q-Pad, an innovative menstrual blood-based health monitoring pad. Qvin’s FDA approval last week was more then just a news story, it’s really a narrative shift, positioning menstrual blood at the very center…

Femtech Insider Partners with Jobbio’s Amply Network to Elevate Femtech Job Search and Talent Acquisition

Today we’re excited to announce that Femtech Insider, the leading media platform in the femtech and women’s health innovation industry, has partnered with Jobbio’s Amply Network, a specialist in talent acquisition technology. Core to this partnership is the launch of Femtech Insider Jobs, a brand-new career platform dedicated to the women’s health innovation industry. Introducing Femtech Insider Jobs By leveraging Femtech Insider’s…

Asieris Pharmaceuticals Establishes Women’s Health Business Unit to Advance Gynecological Care

Asieris Pharmaceuticals has launched a new Women’s Health Business Unit, focusing on advancing treatments in gynecology, particularly for cervical cancer. The initiative centers on APL-1702, a non-surgical treatment for cervical high-grade squamous intraepithelial lesions, positioning the company at the forefront of innovative gynecological care. This move aligns with global health initiatives aimed at combating cervical cancer. The China National Program for Women’s…

Illumina Ventures Labs Launches to Accelerate Genomics Startups in the US and UK

Illumina Ventures Labs, an incubator for early-stage genomics and precision health companies, has officially launched operations in Foster City, California, and Cambridge, United Kingdom. The venture, part of Illumina Ventures, aims to nurture the growth of start-ups in the healthcare sector, particularly those focusing on genomics. Illumina Ventures Labs is finalizing agreements with several startups, providing them access to advanced genomics laboratories…

New Nature Study by Flo Health Reveals How Acute Stress Affects Women’s Pain Perception Amidst Russia-Ukraine War

In a study published by Nature Portfolio Journal: Mental Health Research, Flo Health has illuminated the effects of acute stress on pain perception among women during the ongoing Russia-Ukraine war. This research, marking the first real-world examination of ‘stress-induced analgesia’ (SIA), offers critical insights into the relationship between heightened stress and reduced pain sensitivity. For this study Flo, a women’s health app…

DarĂ© Bioscience Advances DARE-LARC1 Drug Delivery Platform for Women’s Health

DarĂ© Bioscience, a biopharma company specializing in women’s health, has announced the development of DARE-LARC1, a drug delivery platform that can administer therapeutic doses over extended periods. This platform is designed to store and precisely deliver medications for months or years through a single device. The technology behind DARE-LARC1, developed initially at the Massachusetts Institute of Technology by Drs. Robert Langer and…